These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25022930)

  • 1. Validity of the Seattle Heart Failure Model for prognosis in a population at low coronary heart disease risk.
    Laszczyńska O; Severo M; Friões F; Lourenço P; Silva S; Bettencourt P; Lunet N; Azevedo A
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):653-8. PubMed ID: 25022930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.
    Sartipy U; Goda A; Yuzefpolskaya M; Mancini DM; Lund LH
    Am Heart J; 2014 Sep; 168(3):325-31. PubMed ID: 25173544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of mortality risk stratification models for cardiovascular disease.
    Nakayama M; Osaki S; Shimokawa H
    Am J Cardiol; 2011 Aug; 108(3):391-6. PubMed ID: 21600539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
    Mozaffarian D; Anker SD; Anand I; Linker DT; Sullivan MD; Cleland JG; Carson PE; Maggioni AP; Mann DL; Pitt B; Poole-Wilson PA; Levy WC
    Circulation; 2007 Jul; 116(4):392-8. PubMed ID: 17620506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Judgement vs Model-Predicted Prognosis in Patients With Heart Failure.
    Buchan TA; Ross HJ; McDonald M; Billia F; Delgado D; Duero Posada JG; Luk A; Guyatt GH; Alba AC
    Can J Cardiol; 2020 Jan; 36(1):84-91. PubMed ID: 31735429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM).
    Goda A; Williams P; Mancini D; Lund LH
    J Heart Lung Transplant; 2011 Nov; 30(11):1236-43. PubMed ID: 21764604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the Seattle Heart Failure Model in patients with advanced heart failure.
    Kalogeropoulos AP; Georgiopoulou VV; Giamouzis G; Smith AL; Agha SA; Waheed S; Laskar S; Puskas J; Dunbar S; Vega D; Levy WC; Butler J
    J Am Coll Cardiol; 2009 Jan; 53(4):334-42. PubMed ID: 19161882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy.
    Regoli F; Scopigni F; Leyva F; Landolina M; Ghio S; Tritto M; Calò L; Klersy C; Auricchio A;
    Eur J Heart Fail; 2013 Feb; 15(2):211-20. PubMed ID: 23112003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
    Lee DS; Austin PC; Rouleau JL; Liu PP; Naimark D; Tu JV
    JAMA; 2003 Nov; 290(19):2581-7. PubMed ID: 14625335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population.
    Levy WC; Aaronson KD; Dardas TF; Williams P; Haythe J; Mancini D
    J Heart Lung Transplant; 2012 Aug; 31(8):817-24. PubMed ID: 22759798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-variable risk model in men and women with heart failure.
    Chyu J; Fonarow GC; Tseng CH; Horwich TB
    Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of 6-minute walk test in stable outpatients with heart failure.
    Arslan S; Erol MK; Gundogdu F; Sevimli S; Aksakal E; Senocak H; Alp N
    Tex Heart Inst J; 2007; 34(2):166-9. PubMed ID: 17622362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
    Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
    Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tissue Doppler-derived ventricular asynchrony in patients with left bundle branch block but not advanced heart failure.
    Citro R; D'Andrea A; Patella MM; Ducceschi V; Provenza G; De Luca G; Calabrò R; Gregorio G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):568-74. PubMed ID: 17667026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project).
    Fumagalli S; Gasparini M; Landolina M; Lunati M; Boriani G; Proclemer A; Santini M; Mangoni L; Padeletti M; Marchionni N; Padeletti L;
    Am J Cardiol; 2014 May; 113(10):1691-6. PubMed ID: 24792738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy.
    Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Pontecorboli G; De Santo T; Bellocci F; Vitulano N; Emdin M; Mascioli G; Ricceri I; Porciani MC; Michelucci A; Padeletti L
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):88-94. PubMed ID: 22054166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renal dysfunction on the Seattle Heart Failure Model.
    Vakil KP; Dardas T; Dhar S; Moorman A; Anand I; Maggioni A; Linker DT; Mozaffarian D; Levy WC
    J Heart Lung Transplant; 2014 Feb; 33(2):163-9. PubMed ID: 24315784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.